Skip to content

Ayurvedic management of Thyroid

Clinical evaluation of the effect of Kanchnar guggulu Baheda churna & Panchakola churna in the management of dhatwagni mandya (Hypothyroidism)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/019409
Enrollment
40
Registered
2019-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E02- Subclinical iodine-deficiency hypothyroidism

Interventions

Intervention1: Kanchnar guggulu. Baheda churna and Panchkola churna: 1. Kanchnar guggulu- 2 tab BD after meals with lukewarm water 2. Baheda churna- 3 gm BD

Sponsors

Patanjali Ayurveda College
Lead Sponsor
Dr Priyanka Mourya
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Serum T3, T4 and TSH levels which indicates Hypothyroidism. 2. Patients between the age group of 18-60 years of either sex. 3. Patient irrespective of sex, religion, occupation and chronicity will be selected. 4. TSH value : >5.0 mIU/ml -

Exclusion criteria

Exclusion criteria: 1. Patients associated with any other systemic disorders like cardiac problem, carcinoma will be excluded. 2. Thyroid abnormality in pregnancy will be excluded. 3. Patients with complaints of Thyroid tumour will be excluded. 4. Post-operative cases of thyroid abnormality will be excluded. 5. Patients aged 60 years will be excluded 6. Patients suffering from congenital hypothyroidism and secondary hypothyroidism. 7. Hypothyroidism with co-morbid condition

Design outcomes

Primary

MeasureTime frame
1. Serum Tri-iodothyronine(T3) 2. Serum Tetra-idothyronine (T4) 3. Serum Thyroid stimulating hormone (TSH) Timepoint: Before inervention and Ist follow-up of 1 month

Secondary

MeasureTime frame
1. Serum Tri-iodothyronine(T3) 2. Serum Tetra-idothyronine (T4) 3. Serum Thyroid stimulating hormone (TSH) Timepoint: After inervention at 2 months (completion of treatment)

Countries

India

Contacts

Public ContactDr Abhishek Bhushan Sharma

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan Haridwar

ayu.abhishek@gmail.com9458636020

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026